FIELD: chemistry, pharmacology.
SUBSTANCE: composition contains 0.8-2.0 wt % of sodium hyaluronate, 1-3 wt % of sodium alginate and distilled water to 100 wt %. Composition possesses prolonged adhesion to glycosamine-glycan urothelium layer and creates barrier for adhesion of bacteria to affected tissues by covering urothelium with biopolymer film.
EFFECT: composition ensures expressed therapeutic effect, considerably reduces edema of urinary bladder walls, stops or considerably reduces pain syndrome, considerably reduces number of cystitis recurrences.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AQUEOUS COMPOSITION FOR INSTILLATION IN BLADDER | 2015 |
|
RU2586285C1 |
| METHOD FOR TREATMENT AND PREVENTION OF CYSTITIS | 2020 |
|
RU2751649C1 |
| METHOD OF TREATING CYSTITIS | 2013 |
|
RU2537031C2 |
| COMPOSITION FOR INSTILLATION OF URINARY BLADDER WITH INCREASED STABILITY DURING STORAGE, CONTAINING CHONDROITIN SULPHATE (4_5 MG/ML), HYALURONIC ACID (16 MG/ML) AND PHOSPHATE BUFFER (PH 6_1-7_9), FOR TREATING CYSTITIS | 2018 |
|
RU2742277C1 |
| BLADDER INSULATION COMPOSITION CONTAINING CHONDROITIN SULPHATE (20 MG/ML), HYALURONIC ACID (16 MG/ML) AND PHOSPHATE BUFFER (pH 6.1-7.9), WITH INCREASED STORAGE STABILITY FOR CYSTITIS TREATMENT | 2018 |
|
RU2745869C1 |
| INTEGRATED METHOD OF TREATING FEMALE PATIENTS SUFFERING FROM CHRONIC RECURRENT CYSTITIS AND REFRACTORY OVERACTIVE BLADDER | 2013 |
|
RU2550968C1 |
| METHOD OF CONSERVATIVE TREATMENT OF BLADDER LEUKOPLAKIA (SQUAMOUS METAPLASIA) | 2008 |
|
RU2390341C2 |
| METHOD OF TREATMENT AND PREVENTION OF RADIATION CYSTITIS | 2019 |
|
RU2730450C1 |
| AGENT FOR TREATING CHRONIC INFLAMMATORY DISEASES OF URETHRA AND BLADDER | 2015 |
|
RU2602954C1 |
| METHOD OF TREATING AND PREVENTING URINATION DISORDERS | 2019 |
|
RU2708524C1 |
